Palladium-103 brachytherapy with continuous periodic intravitreal Anti-VEGF bevacizumab for ciliary body medulloepithelioma.
Journal: American journal of ophthalmology case reports
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Wingate SL, Finger PT (2026). "Palladium-103 brachytherapy with continuous periodic intravitreal Anti-VEGF bevacizumab for ciliary body medulloepithelioma.". American journal of ophthalmology case reports. https://doi.org/10.1016/j.ajoc.2026.102692